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Abstract
Astroviruses are becoming a growing concern in veterinary and public health. To date there are no registered vaccines
against astrovirus-induced disease, mostly due to the difficulty to cultivate astroviruses to high titer for vaccine
development using conventional techniques. As means to circumvent this drawback, we have developed stably transfected
mink fetal cells and BHK21 cells constitutively expressing the full-length and truncated capsid proteins of two distinct
genotypes of mink astrovirus. Protein expression in these stably transfected cells was demonstrated by strong signals as
evaluated by in-situ PLA and IFA, and confirmed by Western blotting. The recombinant full-length and truncated proteins
induced a high level of antibodies in mink, evaluated by ELISA, demonstrating their immunogenicity. In a challenge
experiment in mink, a reduction in presentation clinical signs and virus shedding was observed in mink kits born from
immunized females. The gene integration and protein expression were sustained through cell passage, showing that the
used approach is robust and reliable for expression of functional capsid proteins for vaccine and diagnostic applications.
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Introduction
Astroviruses are non-enveloped viruses belonging to the
Astroviridae family [1]. Members of this family infect the gastroin-
testinal tract of mammals and birds and are responsible for a large
proportion of non-bacterial diarrhea, particularly in infants and
elderly people, and in newborn of a wide range of animal species
[2,3,4,5,6,7,8,9,10,11,12]. In turkeys and ducks they are further
associated with kidney [13] and liver infections [14]. Infections in
humans are widespread, with antibodies, for example, for HAstV-
1 found in more than 90% of the population [2].
The genome of astroviruses is 6.4–7.3 kb in size, and is positive-
sense, single-stranded polyadenylated RNA. It contains three open
reading frames (ORFs), flanked by 59 and 39 untranslated regions
[15]. ORF1a encodes non-structural proteins, ORF1b codes for
the replicase, and they are translated into a polyprotein through a
ribosomal frameshift mechanism [15]. This polyprotein is a
precursor of the non-structural proteins that are generated from
post-translational processing by viral encoded and cellular
proteases [16,17]. ORF2 at the end of the genome is transcribed
from a single sub-genomic RNA of about 2.4 Kb, and translated
into the capsid protein [18]. The size of the ORF2 product varies
from 671–816 amino acids in different host species and astrovirus
strains [19], and has a molecular mass of approximately 72 to
90 kDa [6,15,20].
Genetic analysis of ORF2 of astroviruses found in man and in
different animal species has shown extensive variation between
and within species [19,21,22,23,24]. Recently, human astroviruses
found in fecal samples from cases of acute gastroenteritis in
children were shown to be genetically related to the mink and
ovine astroviruses [25,26,27]. In addition, an astrovirus found in
the frontal cortex of a boy suffering from agammaglobulinemia
was shown to be genetically close to mink astrovirus [28]. Also, a
close similarity was found between astroviruses from pigs with
those from humans [5,29]. These reports strongly implicate that
astroviruses may be regarded as potential zoonotic agents, which
raises public health concerns and highlights the global relevance of
these pathogens.
The ORF2-encoded capsid protein of astroviruses is the surface
viral protein and has been shown to carry the antigenic
determinants of the virus, it induces neutralizing antibodies [30]
and mediates interactions with the host [31]. Thus, the capsid
protein has been targeted for expression for processing studies
[30,32,33], assembly, and to produce antigenic proteins [34]. The
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full-length capsids of human astrovirus-1 (HAstV-1) and HAstV-2
have been expressed using either recombinant baculovirus
expression system [35] or vaccinia virus expression system [36].
The protein expressed in these systems has been shown to
assemble into virus-like particles (VLPs).
Mink astrovirus (MiAstV) has been described as a causative
agent of pre-weaning diarrhea syndrome in young mink kits [3].
The syndrome, referred to as ‘‘sticky’’, ‘‘greasy’’, or ‘‘wet’’ kits, is
characterized by diarrhea and excessive secretion from cervical
apocrine glands in mink kits, usually at the age of 1–4 weeks
[3,37]. Post mortem examination of kits dying from this syndrome
reveals a non-specific catarrhal enteritis with hydropic epithelial
cell degeneration, infiltration of mononuclear cells in the villous
propria, and hypersecretion of the apocrine neck glands [38].
In a previous evaluation, a full-length capsid protein of mink
astrovirus expressed and purified from E. coli was shown to induce
high level of antibodies in immunized mink (Hammer et al.
unpublished data). However, challenge with astrovirus resulted
only in partial protection from symptoms of pre-weaning diarrhea
and limited virus shedding. A baculovirus-expressed capsid protein
of chicken astrovirus was evaluated to confer partial protection
against the runting stunting syndrome [39]. There is a need to
identify parts of the capsid protein combining immunogenicity
with protective ability, features of an effective vaccine. In order to
determine if truncated capsid proteins could have vaccine features,
initially we constructed five recombinant clones from ORF2,
based on predicted antigenicity plots of the mink astrovirus capsid
protein: the full-length, two N-terminally truncated (CPDN1,
ORF2 nt 480–2325; CPDN2, ORF2 nt 1152–2325) and two C-
terminally truncated (CPDC1, ORF2 nt 1–1863; CPDC2, ORF2
nt 1–1200) forms of ORF2. On preliminary testing of the
corresponding proteins in adult mink, only the full-length, the
CPDN1 the CPDC1 proteins stimulated production of serum
antibodies. Therefore the present study was conducted based on
the constructs and proteins screened as potential vaccine
candidates, in the path to develop a vaccine against mink
astrovirus induced gastroenteritis. We have focused on develop-
ment of a reliable source of recombinant capsid proteins through
the establishment of stable transfected mink fetal and BHK-21
cells constitutively expressing ORF2 forms of two genetically
distinct mink astroviruses, and performed primary challenge
experiments with two of the proteins.
Results
Cloning of the Full-length, N- and C- Terminally
Truncated ORF2
The strategy for amplification of the full-length, N- and C-
terminally truncated ORF2 is depicted in Fig. 1A. Amplicons of
the expected sizes were obtained by PCR (Fig. 1B) and cloned into
the pDual-GC vector. Sequencing of the clones has confirmed the
coding sequence for the capsid protein of mink astrovirus. The
sequence of the ORF2 of mink astrovirus DK5790 was 99%
homologous to the astrovirus sequence deposited in the GenBank
with accession nr AY179509 and diverges by 49% from the
sequence of a mink astrovirus found associated with the shaking
mink syndrome (GenBank accession no. GU985458) (4). The
sequence of ORF2 of mink astrovirus DK7627 is 47 and 44%
divergent, respectively, to the astrovirus sequence of the enteric
astrovirus deposited in the GenBank with accession no.
AY179509, and to the sequence of the CNS disease inducing
astrovirus described by Blomstro¨m et al. (2010) (GenBank acces-
sion no. GU985458) [40].
Constitutive Expression of Astrovirus Capsid Proteins in
Stably Transfected Cells
The three constructs from each astrovirus were successfully
cloned and transfected into mink fetal and BHK-21 cells. The cells
were subjected to G418 selection and the resistant clonal cells were
selected and expanded. The cells were screened by in-situ PLA to
evaluate expression of the cloned genes and to quantify specific
signals for protein expression. Once determined that the signals
are significantly different between cells transfected with ORF2
constructs and mock-transfected cells, IFA was used as a cheaper
method to confirm constitutive expression in the cells. The
transfected cells displayed signals for protein expression uniformly
distributed in the cell cytoplasm as shown by PLA (Fig. 2A) and
IFA (Fig. 2C) in different cell types. There were no differences in
protein expression from different capsid constructs in mink fetal
cells (Fig. 2A) and BHK-21 cells (Fig. 2C), evaluated by PLA and
IFA, respectively.
Cells expressing full-length, CPDN and CPDC recombinant
capsid of strain DK5790 reacted strongly with the antiserum of
astrovirus genotype 1, i.e., homologous serum (Fig. 2A, left, top,
middle and bottom panel, respectively), whereas reactivity to
genotype 2 serum, i.e., heterologous serum was reduced (Fig. 2A,
right, top, middle and bottom panel, respectively), though not
significantly. Mock-transfected cells (negative control) and trans-
fected cells incubated with pre-immune serum (shown for mink
fetal cells transfected with the CP construct) did not show specific
signals for expression of capisd proteins. Quantitation of the in-situ
PLA signals showed a significant difference between signals in
transfected and mock-transfected cells (negative control) (Fig. 2B).
Expression Analysis of Recombinant Capsid Proteins
Protein extracts prepared from transiently and from stably
transfected cells were analyzed for protein expression by Western
blotting with antibodies directed to the astrovirus capsid protein.
In extracts from transient transfections, a band was seen at the
expected size for the full-length protein, approximately 87 kDa,
for both genotypes (Fig. 3A). In transient transfections with
constructs of the CPDN and CPDC constructs of DK5790, a band
of approximately 70 kDa was present in the blots, with secondary
band of approximately 29–32 kDa (Fig. 3B). Bands of approxi-
mately 70 kDa were seen in extracts of cells transfected with
constructs CPDN and CPDC, respectively, of DK7627 (Fig. 3C).
Proteins expressed in transiently transfected cells were in low
amounts. In contrast, expression from stably transfected cells was
higher and sustained through cell passage (Fig. 3D, CP), (Fig. 3F,
CPDN) and (Fig. 3H, CPDC). The same pattern was seen in lysates
of BHK21 cells stably transfected with constructs of astrovirus
DK7627 (Fig. 3E, CP), (Fig. 3G, CPDN) and (Fig. 3I, CPDC). The
protein yield varied between 500 mg and 1mg/ml, following
purification from lysates of confluent cells grown in 175 cm2
surface flasks. An example of proteins purified from cell lysates is
shown in the SDS-PAGE gel of Fig. 4.
Integration of ORF2 Genes in the Transformed Cells
In the Southern blot of DNA extracts from lysates of cells stable
transfected with plasmids CP, CPDN and CPDC, signals from
hybridization of specific astrovirus probe were detected, as shown
for mink fetal cells in Fig. 5. The signals were stronger in stable
than in transiently transfected cells. Since the DNA was not subject
to restriction endonuclease digestion, integration was determined,
but not a map showing the genomic location of the integrated
sequences. This will be subject to further characterization of the
Cells Expressing Mink Astrovirus Capsid Proteins
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expressing cells to analyse the patterns of integration and possible
effects in protein expression.
Immunogenicity of the Expressed Capsid Proteins in
Mink
Preliminary immunizations were performed by subcutaneous
injection of six adult mink, three weeks apart with the CP, CPDN
and CPDC proteins from astrovirus DK5790. Sera from animals
were collected two weeks after each immunization and tested for
antibodies in an ELISA. As illustrated in Fig. 6, the serum
antibody to the capsid proteins showed a significant increase after
the first injection in the immunized groups, compared to non-
immunized group (p,0.005). The antibody level after the first
injection of the CPDC protein was significantly higher than that of
CP and the CPDN proteins (p,0.05) (day 14). Following the
second immunization, the level of antibodies increased signifi-
cantly (p,0.05) in mink injected with the CPDN protein, while it
remained unaltered in the groups of mink injected with the CP
and the CPDC proteins.
Response to Challenge with Mink Astrovirus
Astrovirus infection in mink primarily affects the kits, and the
resulting disease, pre-weaning diarrhea syndrome, can only be
reproduced in mink kits. Therefore, kits born from immunized
female, and from non-immunized mink as controls, were
challenged with astrovirus. Signs of diarrhea were reduced in
days of presentation and severity in kits born from the CP and
CPDC immunized animals, by 70% and 50%, respectively (Fig. 7),
while 100% of kits from non-immunized mothers had severe
diarrhea lasting 5–7 days. In a previous challenge experiment, the
reduction of severe diarrhea had been of 50% in kits from mothers
immunized with a CP protein expressed in bacteria.
Shedder mink were divided into three categories: high shedding,
with astrovirus copy number more than 2*106, moderate shedding
with copy number between 2*103 and 2*106, and low shedding/
negatives with copy number less than 2*103 or no virus detection.
The highest reduction in virus shedding (low or no virus shedding)
was observed in kits from CP immunized mothers (75%), when
virus shedding in kits from non-immunized challenged controls
was high and in 100% of the litters during the critical period for
presentation of diarrhea. Kits from mothers immunized with the
CPDC had moderate shedding detected in 50% of the litters,
compared to controls (Fig. 8).
Discussion
Astroviruses are difficult to culture in vitro, therefore production
of vaccines based on live or inactivated virus has been hampered,
as well as the use of serological tests that depend on growth of virus
such as the neutralization assay. Molecular methods feature as an
attractive approach to develop recombinant proteins for various
purposes, including vaccines and systems to study the biology of
astroviruses. The capsid protein encoded by ORF2 of astrovirus
contains antigenic determinants [30] and mediates interactions
with the host [31]. Genetic analysis of ORF2 gene of mink
astroviruses found in fecal samples shows the existence of different
variants of mink astrovirus (unpublished data). In addition, mink
were recently found to be affected by a central nervous system
disease caused by an astrovirus [40] that is genetically distinct by
up to 47% to published sequences of mink astrovirus. Altogether,
this shows a spectrum of genetic diversity and disease syndromes
induced by mink astrovirus that needs to be taken into account for
effective control of infections by means of vaccination.
In previous work, a recombinant full-length capsid protein of
mink astrovirus produced in bacteria was evaluated for the ability
to induce antibodies and to protect offspring of immunized
pregnant mink upon challenge with astrovirus (Hammer et al.
unpublished data). The results have shown a high level of
antibodies induced by this protein, reduced clinical manifestations
and reduced virus load in kits from immunized females compared
to those of non-immunized controls. As a part of vaccine
development studies, in the present work we have developed a
system to improve expression of recombinant capsid proteins of
astrovirus in order to carry out immunogenicity and protection
studies. We have engineered mammalian cells to integrate the full-
length and truncated forms of ORF2, encoding the capsid protein
of mink astrovirus aiming at expression of proteins with the
modifications that may be required for the protein’s immune
function. The expression of cloned genes in mammalian cells
allows post-translational modifications that do not occur in
Figure 1. (A) Strategy for amplification of the full-length and truncated ORF2 of mink astrovirus. The full-length (CP), and truncated
CPDN and CPDC fragments are represented. (B) Amplicons of the full-length (CP) and N (CPDN), and C- terminally truncated (CPDC) ORF2 of mink
astrovirus generated with primers as described in Methods.
doi:10.1371/journal.pone.0082978.g001
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Figure 2. In situ-PLA and IFA in stable transfected cells. (A) The full-length (CP), N-terminally truncated (CPDN) and C-terminally truncated
(CPDC) ORF2 constructs were transfected into mink fetal (MF) cells, subjected to G418 selection and clonal cells were thereafter tested for expression
of the corresponding proteins by in-situ PLA as described in Methods. Sera to homologous (left panel) and heterologous (right panel) astrovirus were
used, and thereafter cells were stained in an in-situ PLA. The controls were CP transfected and mock-transfected cells incubated with pre-immune
sera or homologous/heterologous serum, respectively and stained as mentioned above. Signals of protein expression were present in the cytoplasm
demonstrating stable transfection and constitutive expression of the indicated forms of the capsid protein in MF cells. (B) Quantitative expression of
all three constructs for homologous (upper panel), heterologous (middle panel) antibodies and difference between homo- and heterologus (lower
panel) is shown, as determined using Duolink ImageTool. (C) BHK21 cells transfected as before with DK7627 constructs were incubated with
homologous serum and stained for IFA. Signals of protein expression were present in the cytoplasm demonstrating stable transfection and
constitutive expression of the indicated forms of the capsid protein in BHK21 cells.
doi:10.1371/journal.pone.0082978.g002
Cells Expressing Mink Astrovirus Capsid Proteins
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Figure 3. Expression of forms of the capsid protein of astrovirus in transient and in stable transfected mink fetal (MF) cells. The
primary antibody was polyclonal serum for genotype 1 astrovirus, i.e. homologous to strain DK5790. Western blotting was performed as described in
Methods. A) Transient expression of the full-length CP of astroviruses DK5790 and DK7627. (B) Transient expression of CPDN and CPDC proteins of
DK5790. (C) Transient expression of CPDN and CPDC proteins of DK7627. (D, F, H) Expression of protein from MF cells stable transfected with CP,
Cells Expressing Mink Astrovirus Capsid Proteins
PLOS ONE | www.plosone.org 5 December 2013 | Volume 8 | Issue 12 | e82978
bacterial systems, therefore maintaining functional features of the
expressed proteins [41].
The stable transfected cells were shown to constitutively express
astrovirus proteins by immunofluorescence and in-situ PLA. The
fact that the expressed proteins reacted well to homologous but
weakly to heterologous sera imply that the sequence differences in
the respective capsid proteins may determine antigenic changes.
Therefore, understanding the immunogenicity of the capsid
protein of different astroviruses and its implications is relevant to
develop effective, broad protective subunit vaccines. The percent-
age of similarity between the two strains is low enough to define
two different species of astrovirus than serotypes within species, as
it has been suggested in the current ICTV taxonomy on
astroviruses.
Western blotting analysis has revealed proteins of the expected
size for the full-length, the N- and the C-terminally truncated
capsid proteins, of approximately 87 and 70 kDa, respectively. In
addition, secondary bands were seen in the blots of CP and CPDN,
which is consistent with the sizes of astrovirus cleavage products
described upon infection in mammalian cells [34,42]. It has been a
common observation that capsid proteins from lysates of stable
transfected cells show as a double band in the Western blots, but
an explanation for this has not been found.
Expression of astrovirus ORF2 in vaccinia [36] and baculovirus
[35] systems have been shown to result in the formation of VLPs.
Despite several attempts we were unable to demonstrate VLP
formation from the capsid proteins expressed in the mink fetal or
BHK-21 cells, probably due to differences in preparation methods.
Although VLP structures could not be demonstrated, the
expressed proteins were shown to elicit an antibody response
when injected in mink, indicating that they carry epitopes for
immunogenicity. This shows that the capsid protein of mink
astrovirus expressed in mammalian cells is immunogenic, as has
been described for the capsid of other astroviruses expressed in
baculovirus [35,39].
Mammalian cells are frequently used as a host for expression of
foreign genes for various functional studies, because they express
proteins in stable biological and functional forms. Despite this,
mammalian cells have not been extensively used to express
recombinant proteins for vaccine purposes, contrary to their
exploitation to grow and produce live attenuated or later
inactivated viruses for vaccines. A common drawback is the low
and unreliable protein expression from transiently transfected
cells, as also seen in the present study. In this work we have used
the approach of expressing the proteins from transfected cells to
overcome limitations with yield and instability of expression. The
stable transfected cells expressed proteins to yields of 500 mg/ml to
1 mg/ml. Moreover, the cloned genes were shown to be stable in
the selected cells. There was no difference in protein expression in
mink fetal and in BHK-21 cells, indicating that stably transfection
could be flexible to different cell types.
The level of protein expression from heterologous genes
introduced into mammalian cells depends upon multiple factors.
These include DNA copy number, efficiency of transfection,
mRNA processing, translational efficiency, protein processing and
variations in codon usage between species. The use of codon-
optimized genes may overcome the latter, improving levels of
expression several fold from randomly optimized sequences [51].
Codon optimization has been reported to significantly increase
protein expression in mammalian [51,52], yeast [53], and bacterial
cells [54]. For parvovirus B19 capsid genes, codon usage rather
than promoter type and sequences of the 39 UTR of the genes
were shown determinant for increased expression in non-
permissive cells [51]. The approach was not used in our studies,
but is a strategy that would enhance protein expression, protein
immunogenicity and reduce costs of scaling up. Different genes
exhibit differences in efficiency of expression [41], thus, optimi-
zation conditions for expression of each gene are often required.
Under the conditions used in our system, we have successfully
integrated astrovirus genes and expressed the corresponding
proteins from stably transfected cells. The system is amenable
for scaling up by use of procedures for large scale tissue culture, for
example in bioreactors, or in 3D cell culture systems, both for
scaling up and for mimicking a suspension environment instead of
growth on flat surface. For properly selected clonal cells it is not
necessary to keep G418 selective pressure.
In the regime tested of immunization of females with
recombinant proteins CP and CPDC at gestation, followed by
CPDN, and CPDC, respectively, of astrovirus DK5790. (E, G, I) Expression of protein from BHK21 cells stable transfected with CP, CPDN, and CPDC,
respectively, of astrovirus DK7627.
doi:10.1371/journal.pone.0082978.g003
Figure 4. SDS-PAGE of purified proteins expressed from stable transfected mink fetal cells. The proteins were purified by nickel affinity
chromatography as described in Methods. Ten microliters of protein were loaded in the gel, separated by electrophoresis and stained with
Coomassie blue.
doi:10.1371/journal.pone.0082978.g004
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challenge of kits with a high virus doses, a reduction in duration
and severity of clinical symptoms was observed in kits, at an
average of 70% and 50%, respectively. The evaluation has shown
protection of kits against severe diarrhea that is the clinical
outcome of astrovirus infection in mink. Thus, the presented
results support the feasibility of a capsid-based vaccine for
protection against astrovirus disease in mink. Further trials will
be performed to optimize the vaccination schedule.
It has been demonstrated that the capsid protein of human
astrovirus type 1 blocks the classical [43] and lectin [44] activation
pathways of the complement system, resulting in suppression of
the downstream complement activation products and inflamma-
tory mediators [43,44,45,46]. The region involved in inhibition of
complement activation has been mapped to span amino acids 79–
139 [31,44]. The CPDN protein, where the truncation spans
amino acids 1–160 presumably can overcome suppression of the
immune system that has been described for the capsid protein.
However, the CPDC clone comprises the amino-terminal part of
the capsid protein that is not processed and has been reported
dispensable for VLPs assembly [47,48]. Immunization of pregnant
mink with this protein has shown to reduce severity of diarrhea in
their born kits at challenge. The level of protection was similar to
that conferred by a bacterially expressed protein in percentage of
litters affected (50%) rather than in severity (the cases recorded
were moderate). This appears to indicate either a limiting effect of
the immunosuppressive region in the context of a truncated
protein.
The molecular mechanism of astrovirus binding to host
receptors has not been elucidated. However, it has been revealed
that the amino acids that are lined up for receptor binding on the
viral capsid protein are highly conserved [49,50]. In line with this,
human astroviruses show pairwise percentage identities of 47–57%
in the capsid protein (in the P2 domain, from amino acid 415–
646). Despite these facts, the two strains investigated in this study
show remarkable differences in their amino acid sequences, which
warrants further studies using predicted protein structures and
crystallography to properly understand the biological relevance of
these differences.
Conclusions
In this work we developed mammalian cells constitutively
expressing the full-length and truncated proteins of the mink
astrovirus capsid protein for evaluation of their vaccine properties.
The proteins were shown to be immunogenic in mink. The full-
length and a truncated protein reduced the presentation and
severity of clinical signs in challenged mink suggesting the
potential a for subunit vaccines that can elicit an immune
response without the risk associated with the use of live or
attenuated virus.
Materials and Methods
Cells and Samples
Mink fetal cells (MF), passage 9, and baby hamster kidney
(BHK-21) cells, passage 17, were grown in DMEM and EMEM
medium, respectively, supplemented with 100 U/ml of penicillin
and 100 mg/ml of streptomycin, 10% horse serum and 2 mM of
L-glutamine, at 37uC in a 5% CO2 incubator. Two fecal samples
(DK5790 and DK7627) from mink kits with diarrhea, identified as
astrovirus positive by electron microscopy and PCR, and with
distinct sequences in the ORF2 region, were used as source of
virus. Virus DK5790 was homologous in the capsid region to the
sequence of mink astrovirus with GenBank accession number
AY179509 [6], while ORF2 of DK7627 had a nucleotide
sequence distance of 47% to the AY179509 sequence.
PCR Amplification of the Full-length and Truncated ORF2
Total RNA was extracted using proteinase K digestion and
phenol/chloroform extraction protocol, followed by ethanol
precipitation in presence of 0.1 M sodium acetate. Precipitated
RNA was recovered by centrifugation at 13000 rpm, and
subsequently washed in 70% ethanol. The RNA pellet was air-
dried and resuspended in 20 ml of RNAse free water. Double
Figure 5. Southern blot for detection of gene integration in stable transfected mink fetal cells. DNA was isolated from cell extracts and
10 mg of each DNA were run on agarose electrophoresis, transferred to Hybond N membrane and hybridized with an astrovirus specific probe.
Transiently transfected and non-transfected cells were included as controls. The signals were revealed by radiography scanning in a phosphorimager.
Hybridization signals were detected in extracts of cells stable transfected with constructs CPDC of DK5790 and DK7627, CPDN of DK5790 and DK7627
(left blot) and CP of DK5790 and DK7627 (right blot). The signals were stronger in stable than in transiently transfected cells, as exemplified with
transient transfection (tt) of CPDN of DK7627.
doi:10.1371/journal.pone.0082978.g005
Cells Expressing Mink Astrovirus Capsid Proteins
PLOS ONE | www.plosone.org 7 December 2013 | Volume 8 | Issue 12 | e82978
stranded-cDNA (ds-cDNA) was prepared using Superscript II
reverse transcriptase and an antisense primer complementary to
the 39 end of the genome for 1st strand synthesis. Thereafter, the
second strand reaction was completed by adding 30 ml of 562nd
strand buffer, 2 ml of dNTPs (10 mM), 1 ml of E. coli DNA ligase
(10 U/ml), 4 ml of E. coli DNA polymerase (10 U/ml), 1 ml of E. coli
RNAse H (2 U/ml) and distilled water to a total volume of 150 ml.
All the reagents used were purchased from Invitrogen. The
reactions were incubated at 16uC for 2 hours, then 2 ml of T4
DNA polymerase was added and incubation was continued for
5 min. The ds-cDNA was purified with phenol/chloroform and
precipitated in ethanol. After pelleting by centrifugation and
washing, the cDNA was used as template for the PCRs.
The full-length (CP), the N-terminus truncated (CPDN) and the
C-terminus truncated (CPDC) fragments of ORF2 were amplified
using Pfu Ultra DNA polymerase (Stratagene) and the primers
listed in Table 1, following the manufacturer’s instructions. Briefly,
a 50 ml reaction containing 5 ml of 106Pfu Ultra buffer, 1 ml of
10 mM DNTPs, 1 ml of each primer (10 mM), 2.5 U of Pfu Ultra
DNA polymerase, 1 ml of ds-cDNA and 40 ml of ddH2O was
amplified using a cycling profile of 2 min of denaturation at 95uC,
followed by 35 cycles of 95uC for 30 s, 55uC for 30 s, and 72uC for
4 min. In the last five cycles of amplification of the CP and the
CPDC fragments of strain DK5790, 1 ml of dm5CTP (Fermentas)
was added to protect an Eam1104I recognition site present at
position 125–131 of ORF2. A final extension for 7 min at 72uC
was added. The PCR products were separated on 1% agarose gels
and the DNA bands were visualized with ethidium bromide
staining, under UV light. The PCR products were purified using
the WizardH SV Gel and PCR Clean-Up System (Promega).
Cloning of the Full-length and Truncated ORF2
The primers used for the PCR carry a recognition site for the
Eam1104 restriction enzyme to facilitate cloning. The pDual-GC
expression plasmid (Stratagene) was selected due to the versatility
of allowing expression both in bacterial and in mammalian
systems. In addition, the vector contains His and c-Myc tags to
allow detection and affinity purification of the expressed proteins.
The PCR products generated for ORF2 of mink astrovirus and the
vector were cleaved with Eam1104I restriction enzyme (Fermen-
tas). The vector was dephosphorylated by treatment with shrimp
alkaline phosphatase. Thereafter the vector and the PCR products
were ligated with T4 DNA ligase. The ligation reaction was used
to transform XL1-Blue MRF cells by electroporation, according to
the manufacturer’s instructions. The bacteria were spread on LB
agar plates containing kanamycin and incubated at 37uC
overnight. Screening for recombinants was done by PCR. The
positive colonies were propagated and used to purify the plasmid
DNA, using WizardH Plus SV Miniprep kit (Promega). The clones
were confirmed by sequencing both strands using the Big Dye
Terminator DNA sequencing kit (Applied Biosystems).
Transfection, Selection and Propagation of Clonal Cells
The plasmid pDual-GC carries a neomycin resistance gene that
confers resistance of successfully transfected cells, under Geneticin
treatment (G418) (Invitrogen). BHK-21 or mink fetal (MF) cells
were transfected with recombinant clones of full-length and
Figure 6. Antibodies to the mink astrovirus capsid proteins
determined by ELISA. Adult mink were injected with proteins CP (A),
CPDN (B) and CPDC (C) combined with Freund’s adjuvant, with two-
week interval. Control mink received PBS plus Freund’s adjuvant
injection on each occasion. The results of an indirect ELISA to determine
antibodies in sera of the mink are presented as mean OD values.
Asterisk show statistically significant difference between the levels of
antibody at two time points (p,0.05).
doi:10.1371/journal.pone.0082978.g006
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truncated fragments using lipofectamineTM2000 (Invitrogen). For
transfection, the cells (1.56105 cells/ml) were grown in 6-well
plates and subsequently transfected with 1 mg of the corresponding
expression clones. The cells were then subcultured in medium
containing 250–500 mg/ml of Geneticin in order to select cells
resistant to neomycin. When clonal cells had been established,
they were checked for integration of the ORF2 genes by PCR.
This procedure was repeated upon cell passaging, to evaluate the
stability of the inserted genes. Cells showing a positive PCR signal
for gene integration were then propagated and analysed for
expression of the proteins. Cells found to express protein were
further propagated and then frozen at 2134uC for future use.
Immunofluorescence Analysis and in-situ PLA on Stably
Transfected Cells
Polyclonal antibody as serum recognizing the astrovirus capsid
protein has been raised by immunization of mink with purified
full-length capsid protein expressed in E. coli. Positive reaction with
the antibody and negative reaction with the pre-immune mink
serum in Western blot using the protein as antigen was used to
evaluate the antibody. The stably transfected cells were grown on
8-well chamber slides and when confluent they were fixed with 4%
paraformaldehyde for 30 minutes. For immunofluorescence, the
cells were permeabilized by incubation with 0.1% of Triton X-100
for 10 minutes, and then incubated with polyclonal antiserum for
mink astrovirus, diluted 1:100 and with pre-immune serum. The
primary antibody was removed and the cells were washed three
times with Tris-buffered saline (TBS) (20 mM Tris-HCl pH7.4;
150 mM NaCl) containing 10 mM glycine. A mouse anti-mustelid
antibody diluted 1:100 was added and incubated at 37uC for 60
minutes. The cells were washed and incubated as mentioned
before with a donkey anti-mouse antibody labeled with Cy3
(Jackson Laboratories) as revealing antibody. The nuclei were
stained by adding Hoechst 33342 (Molecular Probes) for contrast.
The cells were washed as before, mounted and observed in a
fluorescence microscope.
For in situ-proximity ligation assay (PLA), the cells were
permeabilized as before and blocking was done by incubation
with TBS containing 10% goat serum, at 37uC for 60 minutes. As
primary antibody, homologous or heterologous polyclonal serum,
and the pre-immune serum was diluted 1:100 in TBS containing
5% whole goat serum, added to cells and incubated 37uC for 60
minutes. The primary antibody was removed and the cells were
washed three times with TBS containing 0.1% Tween 20 (TBS-T).
Then cells were incubated as before with a mouse anti-mustelid
IgG diluted 1:100. After washing, probing was done with PLA
Figure 7. Scoring for diarrhea at different days post-challenge of mink kits. Mink kits born from mothers immunized with the CP and CPDC
proteins, and born from non-immunized females were observed for duration and severity of diarrhea, and categorized as with moderate/severe
diarrhea, or with mild or no diarrhea. Higher percentage of litters with moderate/severe diarrhea in the critical period of 6 to 12 days post-challenge
was seen in litters from non-vaccinated mothers, whereas they were reduced, and at a later stage in litters from CP and CPDC immunized females
(top panel). The bottom panel reflects the opposite for cases of mild or no diarrhea.
doi:10.1371/journal.pone.0082978.g007
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probes anti-mouse plus and anti-mouse minus. Ligation, amplifi-
cation, detection, and washings in between steps were performed
as recommended by the manufacturer (Olink Biosciences,
Uppsala, Sweden, www.olink.com). The images were captured
Figure 8. Virus shedding in fecal samples evaluated by real-time PCR. Samples collected from the litters at different days post-challenge
with mink astrovirus were analyzed by real-time PCR and graded as high to moderate or low to negative for content of astrovirus as per copy number
criteria described in Methods. The percentage of high/moderate virus shedders was higher in litters of non-immunized and CPDC immunized mink.
doi:10.1371/journal.pone.0082978.g008
Table 1. Primer pairs used for amplification of the full-length (CP), the N-terminus truncated (CPDN) and the C-terminus truncated
(CPDC) fragments of ORF2 of mink astrovirus strains DK5790 and DK7627.
ORF2 gene
Fragment
Primer
designation Sequence (59 to 39)
Position in genome
of AY179509
ORF2 product
size (bp)
CP of strains DK5790
and DK7627
SMC1F
SMC2R
TAC TCT TCA ATG GCG TCC GCC AAT CAG
TAC TCT TCG AAG GTT CTT TGA GGA AAT TGC
4175–4192
6499–6482
2325
2334
CPDN of strain DK5790 SMC3F
SMC2R
TAC TCT TCG ATG TCA TTG AAT TTG ACA
TAC TCT TCG AAG GTT CTT TGA GGA AAT TGC
4655–4672
6499–6482
1842
CPDC of strain DK5790 SMC1F
SMC4R
TAC TCT TCA ATG GCG TCC GCC AAT CAG
TAC TCT TCT AAG CAT AAA GGT GCC ACT ACG
4175–4192
6037–6020
1863
CPDN of strain DK7627 SMC3FN
SMC2R
TAC TCT TCG ATG ATC TCC CTT AAC CTC
TAC TCT TCG AAG GTT CTT TGA GGA AAT TGC
NA
6499–6482
1854
CPDC of strain DK7627 SMC1F
SMC4RN
TAC TCT TCA ATG GCG TCC GCC AAT CAG
TAC TCT TCT AAG GTT GTA GAC AAG CAA GTA
4175–4192
NA
1890
F indicates the forward and R the reverse primer. The recognition site for Eam1104I is in italics. The AAG codon for continuing translation of the protein as fusion to the
c-Myc tag is underlined (in SMC2R, SMC4R and SMC4RN). NA – not applicable.
doi:10.1371/journal.pone.0082978.t001
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in a fluorescence microscope (Nikon Eclipse 2000) using
corresponding filters for Texas Red (point-like PLA signals) and
DAPI (nuclear) staining, with a Coolpix camera and NIS elements
software. The DuolinkH Image Tool was used to quantify the
expression of each protein in the PLA. The total number of point-
like PLA signals (single protein) and the total number of nuclei
(average signal count) were counted after optimizing nucleus size,
blob size, blob intensity and cytoplasm radius. Statistical analysis
was performed using unpaired two-tailed Student t-test. Statistical
significance was taken when p,0.05.
SDS-PAGE and Western Blot Analysis of Expressed
Proteins
The transfected cells were washed with phosphate-buffered
saline and lysed in NP40 lysis buffer (20 mM Tris-HCl [pH 7.6],
150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.5% sodium
deoxycholate, and 0.1% sodium duodecyl sulphate) containing a
complete protease inhibitor cocktail (Boehringer-Mannheim,
Mannheim). The cell extracts were centrifuged at full speed in a
refrigerated Eppendorff centrifuge for 10 minutes. Then, the pellet
and supernatant were mixed respectively with 16 and 46SDS
sample buffer and separated on 12% SDS-PAGE gels. The
proteins were then transferred to a PVDV membrane and
analyzed by Western blotting by incubating successively with a
polyclonal homologous antiserum against mink astrovirus as
primary antibody, a mouse anti-mustelid IgG (dilution 1:100)
and a goat anti-mouse IgG conjugated to horseradish peroxidase
(dilution 1:2000). The incubations were done for 1 hour each step,
with three times 10 minutes washes in PBS-Tween in between.
Development was done using diamino-benzydine (DAB).
Stability of Integrated ORF2 Genes in Transformed Cells
Integration of ORF2 sequences was investigated by Southern
blot analysis. DNA was isolated from cell extracts by proteinase K
digestion followed by phenol-chloroform extraction. The DNA
was separated by electrophoresis in 0.8% agarose gel and
subsequently transferred to Hybond N membranes by capillary
transfer. The membranes were cross-linked, pre-hybridized, and
hybridized with a probe, a 1250 astrovirus bp PCR product
labeled with [32P]-dATP using a random labeling kit (Boehringer
Mannheim). Following consecutive stringency washes with 2x SSC
and 0.5 SSC buffers, the signals were visualized by radiography
scanning in a BioRad FX phosphorimager.
Protein Purification
Following confirmation by Western blotting, the proteins were
purified by nickel affinity chromatography using HistTrapTMcol-
umns (GE Healthcare, Uppsala, Sweden). Typically, cells were
lysed on ice with phosphate buffer containing 20 mM immidazole,
1% v/v of Triton X-100, 5 mg/ml of DNAse I and RNase A. The
lysates were equilibrated in phosphate buffer, pH 7.4 containing
20 mM immidazole as binding buffer, then run through the
affinity columns. The columns were subject to successive washes to
remove unbound material. The proteins were eluted in phosphate
buffer containing 500 mM immidazole, and run through PD10
columns or dialyzed against PBS for buffer exchange. The purity
of the proteins was evaluated by SDS-PAGE and the protein
concentration was determined using the PierceH BCA protein
assay kit (Thermo Scientific, Waltham, MA, USA).
ELISA for Detection of Antibodies to Mink Astrovirus
The antigen used in the ELISA is purified full-length capsid
protein of mink astrovirus expressed in E coli. To detect antibodies
specific to the capsid protein in mink sera, high-binding ELISA
plates, MaxiSorp (Nunc, Roskilde, Denmark) were coated
overnight at 4uC with 100 ng/well of protein, diluted in carbonate
buffer (pH 9.6, SIGMA). The plates were washed three times with
PBS-T (PBS with 0.05% Tween 20) and blocked with 100 ml of
blocking buffer (PBS-T containing 5% of skimmed milk) for
1 hour. After washing, 100 ml serum sera diluted 1:100 in blocking
buffer were added and the plates were incubated at 37uC for
1 hour. A horseradish peroxidase-labeled mouse anti-mustelid IgG
secondary antibody diluted 1:1600 in blocking buffer was added
after washing and the plates incubated at 37uC for 1 hour.
Following washing and 10 minutes incubation with substrate
solution (tetramethylbenzidine) the reactions were stopped by
adding 50 ml of H2SO4. The optical density (OD) was measured at
450 nm with an ELISA microplate reader. The mean OD for the
antigen-negative wells was subtracted from each result and the
OD for each sample was corrected to a positive positive serum
with the limit values of 1.5 to 2.0 OD in each run. Serum samples
from pre-immune mink were used as a negative control with an
OD-value of ,0.2.
Immunogenicity Trial with the CP, CPDN and CPDC
Proteins in Mink
To evaluate immunogenicity, recombinant proteins CP, CPDN
and CPDC of strain DK5790 were tested in mink. Adult female
wild type mink were purchased from an Aleutian mink disease
virus free farm without previously reported problems of astrovirus
infection or other mink pathogens. Fecal samples were tested for
astrovirus by real-time PCR and the sera for antibodies to mink
astrovirus by ELISA, with negative results. The mink were divided
into groups: one was injected with PBS and adjuvant (n = 4), one
injected with the full-length CP (n= 6), one injected with the
CPDN protein (n = 6), and one injected with the CPDC protein
(n = 6). The injections were done subcutaneously with 100 mg of
each purified recombinant astrovirus capsid protein in combina-
tion with Freund’s complete adjuvant. The immunization was
repeated two weeks after the first immunization with the same
amount of protein in Freund’s incomplete adjuvant. Blood samples
were collected prior to immunization and three weeks after each
immunization, and analyzed by ELISA.
Challenge Trial with the CP and CPDC Proteins in Mink
Adult female wild type mink were purchased from a farm
without previously reported problems of astrovirus infection or
other mink pathogens. The mink were tested for astrovirus and for
antibodies to mink astrovirus, with negative results. Thereafter
they were divided into groups of six mink each and immunised as
follows: two groups were each injected subcutaneously with
100 mg of proteins CP and CPDN and adjuvant mix; and one
group consisted of non-immunized mink. The immunization was
repeated three weeks after. The kits born from these females were
exposed orally to a high dose of challenge astrovirus (10 million
virus copies per millilitre). Clinical symptoms were recorded in the
litters on a daily basis. Fecal samples were collected at different
days post-challenge throughout the observation period and tested
in a quantitative real-time PCR for determination of virus
shedding after challenge. A standard curve was created based on
a reference strain from experimentally infected mink, diluted 10-
fold dilutions. The virus copy number was calculated and assigned
to each dilution.
All animal experiments were conducted at the National
Veterinary Institute, Technical University of Denmark in accor-
dance with both institutional and national guidelines (Danish
Animal Experiments Inspectorate, Permit Number: 2012-15-
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2934-00524). The experiments were approved by the Danish
Animal Care and Ethics Committee, Denmark.
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